MRKR
MRKR
NASDAQ · Biotechnology

Marker Therapeutics Inc

$1.14
+0.03 (+2.70%)
As of Aug 15, 2:29 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.80M
Net Income
-13,014,397
Gross Margin
Profit Margin
-343.0%
Rev Growth
-26.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.80M 5.18M 3.86M 4.10M
Gross Profit 2.51M 2.67M
Operating Income -13,794,337 -16,939,423 -161,214 -174,270
Net Income -13,014,397 -15,981,658 -155,305 -171,738
Gross Margin 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Rev Growth -26.7% -26.7% +19.6% -4.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.32M 9.35M
Total Equity 11.45M 10.87M
D/E Ratio 0.81 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,790,838 -17,875,966 -205,551 -243,961
Free Cash Flow -168,121 -167,490